{"result": "(\"entity\"<|>DIABETES MELLITUS TIPO 1<|>EVENT<|>Diabetes mellitus tipo 1 is an autoimmune condition that frequently associates with other autoimmune diseases, particularly thyroid disorders.)\n##\n(\"entity\"<|>ENFERMEDAD DE ADDISON<|>EVENT<|>Addison's disease is an autoimmune condition that can develop in patients with other autoimmune disorders, including diabetes mellitus type 1.)\n##\n(\"entity\"<|>SÍNDROME POLIGLANDULAR AUTOINMUNE TIPO 1<|>EVENT<|>Type 1 autoimmune polyglandular syndrome is a rare syndrome characterized by autoimmune conditions including hypoparathyroidism, mucocutaneous candidiasis, and Addison's disease.)\n##\n(\"entity\"<|>SÍNDROME POLIGLANDULAR AUTOINMUNE TIPO 2<|>EVENT<|>Type 2 autoimmune polyglandular syndrome is more common than type 1 and is associated with genetic factors, particularly HLA-DR3.)\n##\n(\"entity\"<|>INSUFICIENCIA OVÁRICA PRIMARIA<|>EVENT<|>Primary ovarian insufficiency is defined by primary hypogonadism before the age of 40 in women, leading to clinical symptoms such as amenorrhea and elevated gonadotropins.)\n##\n(\"entity\"<|>AUTOANTICUERPOS<|>EVENT<|>Autoantibodies are markers that can indicate autoimmune conditions, including those affecting the ovaries and adrenal glands.)\n##\n(\"relationship\"<|>DIABETES MELLITUS TIPO 1<|>ENFERMEDAD DE ADDISON<|>Diabetes mellitus tipo 1 is frequently associated with the development of Addison's disease due to its autoimmune nature.<|>7)\n##\n(\"relationship\"<|>SÍNDROME POLIGLANDULAR AUTOINMUNE TIPO 1<|>ENFERMEDAD DE ADDISON<|>Type 1 autoimmune polyglandular syndrome includes Addison's disease as one of its components.<|>8)\n##\n(\"relationship\"<|>SÍNDROME POLIGLANDULAR AUTOINMUNE TIPO 2<|>AUTOANTICUERPOS<|>Type 2 autoimmune polyglandular syndrome is associated with the presence of autoantibodies, indicating an autoimmune process.<|>6)\n##\n(\"relationship\"<|>INSUFICIENCIA OVÁRICA PRIMARIA<|>SÍNDROME POLIGLANDULAR AUTOINMUNE TIPO 2<|>Primary ovarian insufficiency can be part of the clinical picture in type 2 autoimmune polyglandular syndrome.<|>5)\n##\n(\"relationship\"<|>SÍNDROME POLIGLANDULAR AUTOINMUNE TIPO 1<|>SÍNDROME POLIGLANDULAR AUTOINMUNE TIPO 2<|>Both types of autoimmune polyglandular syndromes involve autoimmune mechanisms and can present with overlapping symptoms.<|>4)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: icos y alargados y destrucción de las células de la teca.\nC. Si con el tiempo la paciente desarrolla un hipoparatiroidismo autoinmune estaríamos ante un síndrome poliglandular de tipo 2.\nD. Es posible que esta paciente esté en riesgo de desarrollar una enfermedad de Addison, por lo que puede ser aconsejable medir anticuerpos antiadrenales o anti-21 hidroxilasa.\n---\n# GÓNADAS, SÍNDROME POLIGLANDULAR AUTOINMUNE Y MISCELÁNEA\n\n## COMENTARIO\n\nLa diabetes mellitus tipo 1 de origen autoinmune se asocia frecuentemente a otras patologías autoinmunes, sobre todo tiroideas. Los anticuerpos antitiroideos aparecen en la quinta parte de pacientes al diagnóstico de diabetes mellitus tipo 1 y predicen la aparición clínica de enfermedad tiroidea posteriormente, razón por la que se recomienda la determinación anual o cada 2 años de la función tiroidea en pacientes que sufren este tipo de diabetes. Otras patologías son menos frecuentes, como la anemia perniciosa, la artritis reumatoide, la enfermedad celíaca o la enfermedad de Addison autoinmune.\n\nLa insuficiencia ovárica primaria se define por un hipogonadismo primario antes de los 40 años en mujer 46,XX. Se traduce clínicamente por amenorrea de 4 meses junto a gonadotrofinas elevadas. Por tanto, la paciente padece una insuficiencia ovárica primaria.\n\nNo disponemos de autoanticuerpos ováricos validados como marcadores de autoinmunidad ovárica, por lo que su asociación a otras patologías autoinmunes sugiere este origen, en nuestro caso, la diabetes mellitus tipo 1 y la tiroiditis crónica autoinmune. La presencia de autoanticuerpos anticélulas suprarrenales o anti-21-OHasa, que frecuentemente se adelantan a la enfermedad de Addison, podría incluir a la paciente en un SPA tipo 2 (en vez de en el SPA tipo 3).\n\nLo más probable es que nos encontremos ante una ooforitis de tipo autoinmune en el contexto de un SPA tipo 2.\n\nAlgunas particularidades podrían diferenciar la ooforitis autoinmune de una menopausia de otro origen: la afectación de las células tecales secretoras de E2 es selectiva, por lo que el E2 está bajo y la LH elevada, pero se conserva la secreción de la inhibina B por las células de la granulosa, motivo por el cual la FSH no es tan elevada. Histológicamente la ooforitis autoinmune se caracteriza por infiltración linfocítica de folículos antrales y secundarios, con preservación de los primordiales. Dicha infiltración linfocítica predomina en la teca de folículos en desarrollo y está asociada con intensa luteinización de los folículos, representado por los ovarios quísticos y alargados de nuestra paciente.\n\nReferencias:\n- Arlt W. Trastornos de la corteza suprarrenal. En: Kasper y cols, eds. Harrison Principios de Medicina Interna. 19.ª ed. McGraw-Hill; 2015. p. 2309-29.\n- Nieman LK, MD. Causes of primary adrenal insufficiency (Addison's disease). Lacroix A, ed. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com (Last updated: Feb 20, 2019.)\n- Welt CK. Clinical features and diagnosis of autoimmune primary ovarian insufficiency (premature ovarian failure). Barbieri RL, Crowley WF, eds. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com (Last updated: Sep 25, 2019.)\n\n## 35. Respecto a los síndromes poliglandulares autoinmunes (SPA) señale la respuesta correcta:\n\nA. El SPA de tipo 1 se hereda de forma autosómica dominante.\nB. No se conoce el gen relacionado con el SPA de tipo 1.\nC. El SPA de tipo 1 afecta mucho más a mujeres.\nD. El SPA de tipo 2 se asocia al antígeno de histocompatibilidad HLA-DR3.\n\n## COMENTARIO\n\nEl SPA de tipo 1 es un síndrome muy raro (menos de 500 casos en el mundo) originado por mutaciones en el gen regulador autoinmune AIRE en el cromosoma 21, transmitido con patrón autosómico recesivo, y que afecta algo más a las mujeres. Asocia la tríada hipoparatiroidismo, candidiasis mucocutánea y enfermedad de Addison.\n\nEl SPA de tipo 2 es más frecuente que el anterior (5/100.000). Presenta un patrón de herencia poligénica con asociaciones con la región génica HLA-DR3 en el complejo mayor de la histocompatibilidad, y distintas regiones génicas que participan\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}